Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Podcast: New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease

Access Activity

Overview / Abstract:


Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; however, involvement of other sites such as the liver, gastrointestinal tract, joints, fascia, and lungs can occur alone or concurrently (LLS, 2022). In recent years, advances in the management of other HSCT"related complications such as cytomegalovirus and invasive fungal infections have led to substantial reductions in mortality (Rahi et al, 2021). Despite intensive research, GVHD remains a challenge due to its heterogeneity and complex pathogenesis (Malard et al, 2020). In this podcast, Shernan Holtan, MD, of the University of Minnesota and Carrie Kitko, MD, of Vanderbilt University Medical Center will explore new biomarkers used for diagnosis and therapy selection, discuss the latest clinical trial findings, and advise practitioners on how to individualize treatment to patients’ needs.


Hematology/oncology physicians, nurse practitioners, physician associates, oncology nurses, and other health care professionals involved in the treatment of patients with graft-versus-host disease (GVHD).


Upon completion of this activity, participants should be able to

Appraise emerging insights into biomarkers for improved diagnosis and therapy selection in GVHD
Assess recent clinical trial findings on the efficacy and safety of emerging therapies for acute and chronic GVHD
Evaluate the implications of recent clinical advances in GVHD for supporting patients and meeting their individual care needs


Aug 21, 2023


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME



Credits / Hours

1.25 CME | 1.25 NCPD | 1.25 CPE | MOC | ILNA



Presenters / Authors / Faculty

Shernan Holtan, MD (Chairperson)
Associate Professor of Medicine
University of Minnesota

Carrie Kitko, MD
Associate Professor of Pediatrics
Vanderbilt University Medical Center

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Incyte.

Keywords / Search Terms

i3 Health i3 Health i3 Health i3 Health i3 Health, CRPC, oncology, CME, CE, free CE, free CME, ILNA points Free CE CME Free CE CME Free CE CME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map